# Regional Lipolysis and Adipocyte Lipolysis Protein Stimulation

> **NCT06416969** · EARLY_PHASE1 · RECRUITING · sponsor: **Mayo Clinic** · enrollment: 24 (estimated)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Somatostatin
- **DRUG:** Epinephrine

## Key facts

- **NCT ID:** NCT06416969
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-01
- **Primary completion:** 2027-04-01
- **Final completion:** 2027-04-01
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2025-12-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06416969

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06416969, "Regional Lipolysis and Adipocyte Lipolysis Protein Stimulation". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT06416969. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*